The Size of the Polymerase Chain Reaction Market in Latin America is valued at USD 1.07 billion in 2022 and estimated to be growing at a CAGR of 6.70%, to reach USD 1.48 billion by 2027 during the forecast period 2022 to 2027.
Polymerase chain response (PCR) is a method used as a part of molecular biology to increase a single or a few copies of a portion of DNA over several orders of magnitude, producing thousands to a large number of duplicates of a specific DNA sequence.
PCR strategies have prepared for development in life sciences research and sub-atomic diagnostics through its most potent elements, for example, absolute identification and Quantification of DNA and RNA. Analysts can analyze and quantify uncommon alleles and point mutations utilizing advanced PCR frameworks, for example, computerized PCR.
The developing geriatric populace, combined with an increasing predominance of chronic diseases, and technological progressions in the field of life science are the key variables driving the development of qPCR and dPCR market. The rising rate of infectious diseases and genetic disorders and expanded public-private speculations, finances, and grants for PCR-based research are further helping the market development. The high cost of dPCR instruments and technological limitations related to qPCR and dPCR are the key components restricting the development of this market.
This research report on the Latin America Polymerase Chain Reaction Market has been segmented and sub-segmented into the following categories
By Type Of Application:
Noteworthy Companies dominating the Latin America Polymerase Chain Reaction Market Profiled in the Report are Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, GE, Harvard Bioscience, Maxim Biotech, Promega, Kapa Biosystems, RainDance Technologies, and Siemens Healthcare.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]